Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Venture Capital To Indian Biotechs Lagging This Year

This article was originally published in PharmAsia News

Executive Summary

Venture capital investments in Indian biotechs have dropped, according to a report on the first quarter of this year. Dow Jones VentureSources counted $11 million invested in only two biopharmaceutical deals during that three-month period. Last year, $99.5 million was invested in life sciences and health care companies in India. An official at MPM Capital, which with TPG Ventures, was among early investors in early-stage biotechs in India, says he still expects the number of life sciences deals to grow. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts